COLIBIOGEN INJECT N, 10x2 ml

Upute za korištenje COLIBIOGEN INJECT N, 10x2 ml

Insurance information

COLIBIOGEN INJECT

Composition:
1 ml contains:
Active pharmaceutical ingredients:
Cell-free solution from 2.7 x 108 lysed Escherichia coli, strain laves other ingredients:
Sodium chloride, glucose, amino acids, water for injection purposes

Dosage form and content:
2 ml solution for injection

Indication
Therman mucosal therapeutic immunotherapeutic

Pharmaceutic entrepreneur:
Laves-Arzneimittel GmbH, Barbarastraße 14, D-30952 Ronnenberg

Application areas:
before, during and after chemotherapy
before, during and after radiotherapy: radiogenic colitis
Gastrointestinal diseases with spastic appearances
For endogenous loading of the intestinal wall
Painful divider disease
Allergies: hay fever, polymorphic light dermatosis
Neurodermitis

Contraindications:
There are evidence that in individual cases in patients with autoimmune-thyroiditis, hypersensitivity reactions could be triggered.
There are no investigations for the use of Colibiogen® Inject during pregnancy and lactation.

Precautions for the application and interaction with other medicinal products:
No interactions have been observed with other preparations.
If hypersensitivity reactions occur, the preparation is to be deducted.
Due to possible reactions, it is generally recommended to keep patients under observation after an injection of Colibiogen® Inject as usual for a short time. This applies in particular to patients with allergic reading readiness.
Slow execution of the injection of Colibiogen® Inject prevents the described side effects.

Warnings:
No

Dosage instructions, type and duration of the application:
Unless otherwise prescribed, at a distance of 1-2 days per 1 Ampoule slow i. v. (more than two minutes per ampoule) or i. m. Inject, later at greater intervals.
In severe cases, the dosage can be increased up to 3 x 1 ampoule daily.
Special dosage accompanying chemotherapy:
Unless otherwise prescribed, 0.167 ml Colibiogen® Inject per kg of body weight in 250 ml of isotonic sodium chloride solution over 30 min. Before the administration of the chemotherapeuticism i. v. Infused.

Side effects:
After colibiogen® injections were very rarely observed allergic reactions of all severity levels. A.A. The following symptoms were observed: redness at the injection site; Redness and swelling in the face (flush); Rashes, in particular nessel fever; Breathing difficulty up to the respiratory distress, asthma; Gastrointestinal symptoms such as nausea, diarrhea; Circular weakness; In a case shock (circulatory collapse) with pre-existing autoimmune thyroiditis. Temporary taste and odor changes occurred occasionally.
If you are observing side effects that are not described in the leaflet, please tell your doctor or pharmacist.

Notes on durability:
The expiry date is printed on the ampoule and on the pack. After this date, Colibiogen® Inject can no longer be used.
After breaking the ampoule or after preparation of the infusion solution, this must be used immediately.

Status of Information: March 2001
Source: www. laves-pharma. de